Disease/Condition
335 Clinical Trials
10+ Countries
HIV Infection Clinical Trials Database - Free Access to 335 Studies
Access comprehensive clinical trial information for HIV Infection through Pure Global AI's free database. This collection includes 335 clinical trials across multiple phases including N/A, Phase 3, Phase 1. Currently, 14 trials are actively recruiting participants.
Research for HIV Infection is being conducted in United States of America, Spain, France and 7+ other countries. Leading sponsors include National Institute of Allergy and Infectious Diseases (NIAID) and University of North Carolina, Chapel Hill. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Free Database
Powered by Pure Global AI
840K+ Global Trials
Updated Daily
By Phase
N/A
149Phase 3
44Phase 1
42Phase 4
41Phase 2
39By Status
Completed
253Unknown
24Terminated
20Recruiting
14Not yet recruit...
9Top Countries
United States of America111
Spain19
France17
Italy13
Canada11
Top Sponsors
National Institute...23
University of Nort...20
GlaxoSmithKline14
ANRS, Emerging Inf...13
National Cancer In...9
Recent Trials
Latest clinical trials for HIV Infection
NCT05993767
Phase 2
Not yet recr...
UNIVERSAL 1: Pharmacokinetic Study of a Novel DTG/FTC/TAF Dose Ratio for Children
PENTA Foundation
2020-001426-57
Ongoing
A randomised non-inferiority trial with nested PK to assess DTG/3TC fixed dose formulations for the maintenance of virological suppression in children
Fondazione Penta Onlus
NCT05766501
Phase 3
Recruiting
A Study of Doravirine/Islatravir (DOR/ISL, MK-8591A) for the Treatment of Human Immunodeficiency Virus 1 (HIV-1) Infection in Participants Who Previously Received DOR/ISL (MK-8591A-054)
Merck Sharp & Dohme LLCAustralia,Canada,Israel,Japan,Puerto Rico,Russian Federation,Taiwan,United States of America
NCT05652088
Not yet recr...
The Role of the Gastrointestinal-associated Lymphoid Tissue in the Cure of HIV Infection
Icahn School of Medicine at Mo...United States of America
NCT05208125
Phase 1
Active, not ...
A Phase I, Randomized, Double-Blind, Placebo-Controlled Safety, Tolerability and Immunogenicity Study of Candidate HIV-1 Vaccines ChAdOx1.HTI and MVA.HTI With Recombinant HIV-1 Envelope Protein ConM SOSIP.v7 gp140 Vaccine, Adjuvanted With MPLA Liposomes in ART-Suppressed HIV-1 Positive Individuals
IrsiCaixaSpain
NCT05085158
Not yet recr...
Pathogen Detection in HIV-infected Children With Non-malarial Febrile Illnesses Using Metagenomic Sequencing
Makerere University
NCT05079347
Not yet recr...
Traditional Healer-initiated HIV Counseling and Testing in South Africa
Vanderbilt University Medical ...
NCT05085717
Recruiting
Prevention, Access to Rights, Catch-up Vaccination, Treatment of Conditions During Pregnancy and for Children
Raincy Montfermeil Hospital Gr...France
NCT04915469
Completed
Enhanced Adherence Counselling, Pre-Post Study
Elizabeth Glaser Pediatric AID...Kenya
NCT04914130
Not yet recr...
A Prospective, Observational Study to Examine the Effects of Ageing on the Clinical Outcomes of People Living With HIV in South Korea
Yonsei UniversitySouth Korea
NCT04860323
Recruiting
Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 703/HPTN 081 AMP Study
HIV Vaccine Trials NetworkBotswana,Malawi,South Africa,Zimbabwe
NCT04897243
Recruiting
Antiretroviral Speed Access Program
Dr. Bertrand LeboucheCanada
NCT05154513
Recruiting
Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV
International Maternal Pediatr...Botswana,Brazil,Haiti,Kenya,Malawi,South Africa,Tanzania,Thailand,Uganda,United States of America,Zi
NCT04801758
Recruiting
Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 704/HPTN 085 AMP Study
HIV Vaccine Trials NetworkBrazil,Peru,United States of America
NCT04340596
Phase 1
Recruiting
Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption
National Institute of Allergy ...United States of America
NCT04295460
Phase 4
Recruiting
Triple vs. Double Therapy in naïves HIV-Infected Patients
Hospitales Universitarios Virg...Spain
NCT04265950
Phase 4
Recruiting
Establishing Optimal Number of Doses for HPV Vaccination in Children and Adolescents Living With HIV, OPTIMO Trial
Fred Hutchinson Cancer Researc...Brazil,Peru
NCT04223778
Phase 3
Not yet recr...
Safety and Efficacy of a Switch to Doravirine/Islatravir in Participants With HIV-1 (MK-8591A-017))
Merck Sharp & Dohme Corp.Australia,Canada,Chile,Colombia,France,Italy,Japan,New Zealand,Poland,Russian Federation,South Afric
NCT04223791
Phase 3
Not yet recr...
Switch to Doravirine/Islatravir (DOR/ISL) in Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-018)
Merck Sharp & Dohme Corp.Australia,Austria,Canada,Finland,France,Germany,Italy,Japan,Puerto Rico,Spain,United States of Ameri
NCT04720742
Phase 2
Suspended
Immune Therapy and Analytical Treatment Interruption in HIV+ Participants Who Received an Allogeneic Stem Cell Transplantation
IrsiCaixaItaly,Netherlands,Spain
About HIV Infection Research
Pure Global AI provides free access to 335 clinical trials studying HIV Infection, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include National Institute of Allergy and Infectious Diseases (NIAID), University of North Carolina, Chapel Hill, GlaxoSmithKline, among others.
Quick Facts
Total Trials335
Countries10+
Sponsors10+
Recruiting14